肿瘤患者中无症状SARS-CoV-2感染的[18F]-FDG PET/CT表现
在西班牙疫情高峰地区,145例因肿瘤指征行PET/CT且无COVID-19症状的患者中,7例(4.8%)出现疑似SARS-CoV-2感染的肺部影像表现,其中5例经RT-PCR确诊COVID-19。结果表明无症状SARS-CoV-2感染患病率高于预期,PET/CT有助于早期诊断COVID-19。
要点
- 肿瘤患者中无症状SARS-CoV-2感染并不罕见,本研究检出疑似影像表现者占4.8%。
- 磨玻璃影伴低[18F]-FDG摄取是PET/CT提示SARS-CoV-2感染的影像特征。
- PET/CT可早期发现无症状COVID-19,便于及时隔离和后续处理。
核心结论
- 肿瘤患者中无症状SARS-CoV-2感染患病率高于预期,PET/CT可早期诊断COVID-19。
研究设计与样本
- 在西班牙疫情高峰期纳入145例符合纳入和排除标准、因肿瘤指征行PET/CT且无COVID-19症状的患者。
- 将既往描述的磨玻璃影伴低[18F]-FDG摄取视为疑似SARS-CoV-2感染的影像表现。
- 对出现疑似影像表现的患者转诊行RT-PCR检测并密切随访以确认或排除COVID-19。
主要发现
- 145例中7例(4.8%)出现疑似SARS-CoV-2感染的肺部影像表现。
- 7例疑似患者中5例经RT-PCR确诊SARS-CoV-2感染(COVID-19)。
- 其余2例未能经RT-PCR确认COVID-19,其中1例PET/CT早期诊断了细菌性肺炎并接受抗生素治疗。
关键数值与推荐
- 疑似SARS-CoV-2感染的影像标准为磨玻璃影伴低[18F]-FDG摄取。
临床怎么用
- 肿瘤患者行PET/CT时若见磨玻璃影伴低[18F]-FDG摄取,应警惕无症状SARS-CoV-2感染并转诊RT-PCR检测。
- 对疑似患者应密切随访,以确认或排除COVID-19并及时处理其他肺部感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Spain has been one of the most affected countries by the COVID-19 pandemic, being among the countries with worse numbers, including the death rate. However, most patients are asymptomatic, although they are very contagious. The objective of this study was to investigate the incidence in oncological patients infected with SARS-CoV-2 that are asymptomatic for COVID-19 and at home and that undergo PET/CT for oncologic indications, nonrelated to COVID-19, finding in the PET/CT lung alterations that are suggestive of SARS-CoV-2 infection. METHODS: During the period of maximum incidence of the global pandemic in one of the most affected regions of Spain, there were 145 patients that met inclusion and exclusion criteria and were included in the study. Imaging findings previously described such as ground-glass opacities with low [18F]-FDG uptake were considered images suspicious for SARS-CoV-2 infection. Patients with these findings were referred to RT-PCR testing and close follow-up to confirm the presence or absence of COVID-19. RESULTS: Suspicious lung imaging findings were present in 7 of 145 patients (4.8%). Five of these 7 patients were confirmed as presenting SARS-CoV-2 infection, this is, COVID-19. In the remaining two, it was not possible to confirm the presence of COVID-19 with RT-PCR, although in one of them, PET/CT allowed an early diagnosis of a lung infection related to a bacterial pneumonic infection that was promptly and adequately treated with antibiotics. CONCLUSION: These results confirm that the prevalence of SARS-CoV-2 infection is higher than suspected and that there are asymptomatic patients that are attending imaging departments to be explored for their baseline oncologic processes. In these patients, PET/CT allows an early diagnosis of COVID-19.
引用
- Cabrera Villegas A, Romero Robles LG, Boulvard Chollet XLE, et al. [18F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32936372. doi:10.1007/s00259-020-04979-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。